Lin, J., & Frey, M. K. (2021). Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer. Gynecologic oncology reports, 38, 100843. https://doi.org/10.1016/j.gore.2021.100843
Chicago-Zitierstil (17. Ausg.)Lin, Jenny, und Melissa K. Frey. "Reply to Dr. Witjes Regarding Universal Tumor Genomic Sequencing as a Prescreen for Germline Genetic Testing in Patients Diagnosed with Ovarian Cancer." Gynecologic Oncology Reports 38 (2021): 100843. https://doi.org/10.1016/j.gore.2021.100843.
MLA-Zitierstil (9. Ausg.)Lin, Jenny, und Melissa K. Frey. "Reply to Dr. Witjes Regarding Universal Tumor Genomic Sequencing as a Prescreen for Germline Genetic Testing in Patients Diagnosed with Ovarian Cancer." Gynecologic Oncology Reports, vol. 38, 2021, p. 100843, https://doi.org/10.1016/j.gore.2021.100843.